WANBURY LIMITED
WANBURY · General/Diversified · NSE
₹258
Current Market Price
Fair Value (DCF)
₹242
Margin of Safety
-6.2%
Updated 11h ago
YieldIQ Score
43/100
Piotroski F-Score
4/9
Economic Moat
Narrow
Confidence
21%
ROE
—
Debt/Equity
0.00
WACC
11.1%
Market Cap
₹903 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
27.8%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
1.8×
EBIT covers interest
Current Ratio
1.11×
Short-term liquidity
Asset Turnover
1.43×
Revenue per ₹ of assets
Revenue CAGR (3Y)
5.4%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹258.31
Bear case
₹137.73
MoS -87.5%
Base case
₹242.4
MoS -6.6%
Bull case
₹314.94
MoS +18.0%
Ratio Trends
WANBURY · last 4 annual periods
ROE
51.5%
ROCE
33.8%
Operating Margin
—
Debt / Equity
2.98×
PE
—
EV / EBITDA
—
Historical Financials
WANBURY · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹393 Cr | ₹511 Cr | ₹133 Cr | ₹139 Cr | ₹594 Cr | +10.9% |
| EBITDA | — | ₹113 Cr | ₹23.5 Cr | ₹98.5 Cr | ₹79.8 Cr | -8.4% |
| EBIT | ₹10.7 Cr | ₹103 Cr | ₹8.4 Cr | ₹41.4 Cr | — | +40.3% |
| PAT | ₹-12.6 Cr | ₹82.5 Cr | ₹1.0 Cr | ₹33.6 Cr | ₹30.5 Cr | — |
| EPS (diluted) | ₹-5.04 | ₹1.91 | ₹0.49 | ₹2.37 | — | — |
| CFO | ₹16.7 Cr | ₹37.6 Cr | ₹19.8 Cr | ₹4.0 Cr | ₹26.1 Cr | +11.8% |
| CapEx | — | — | — | — | ₹-49.0 Cr | — |
| FCF | — | — | — | — | ₹-22.9 Cr | — |
| Total Assets | — | ₹353 Cr | ₹304 Cr | ₹343 Cr | ₹414 Cr | +4.1% |
| Total Debt | — | — | ₹64.1 Cr | ₹28.0 Cr | ₹177 Cr | +28.9% |
| Shareholders' Equity | — | — | ₹-32.8 Cr | ₹27.9 Cr | ₹59.3 Cr | — |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
WANBURY vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| SIGACHI SIGACHI | — | — | Pending | 11.3% | — |
| THEMISMED THEMIS MEDICARE LTD. | -46.2% | 46 | Overvalued | 7.4% | — |
| ANUHPHR ANUHPHR | — | — | Pending | 14.5% | — |
| AHCL AHCL | — | — | Pending | 25.5% | — |
| AMANTA AMANTA HEALTHCARE LIMITED | -52.8% | 31 | Overvalued | 10.9% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for WANBURY in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. WANBURY LIMITED (WANBURY.NS) trades at 258.31 vs a model fair value of 242.40, a gap of -6.2%. Piotroski F-score: 4/9. Moat label: Narrow...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of WANBURY →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for WANBURY →
Compare
Head-to-head with peers
Compare WANBURY side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse WANBURYNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.